Overview
Lumonus AI is a healthcare technology platform designed to transform cancer care through AI-native clinical infrastructure, specifically for radiation oncology. It automates and orchestrates critical oncology workflows to enhance quality, accelerate care delivery, and reduce the administrative burden on healthcare professionals. The platform integrates with major EMR, OIS, and TPS systems, acting as an intelligent assistant that automates tasks such as clinical preparation, documentation, and treatment planning. Lumonus offers two main product lines: Lumonus AI Physician and Lumonus AI Dosimetry. The Physician suite automates workflows for radiation oncologists, including diagnosis, AI-powered prescriptions, and outcomes tracking. The Dosimetry product focuses on transforming treatment planning with features for centralized management, automated planning, and web-enabled reviews. The Lumonus AI software includes a module called Sigma that suggests treatment protocols based on prior treatment plans for similar patients, utilizing machine learning to analyze cancer type and overall risk. Lumonus serves oncology clinics of all sizes in the US, Australian, and UK markets.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI assistant for every role, reducing repetitive work
- Integration with all major EMR, OIS + TPS systems
- Elimination of manual data entry through seamless integration and intelligent extraction
- Automation of administrative tasks and routine processes
- Structured data capture and codified care preferences for quality and efficiency
- Embedded clinical and operational dashboards for actionable insights
- HIPAA compliant integrated messaging and task coordination
- Real-world data informs future patient care by learning from prior patient outcomes
- Context-aware clinical assistant for consulting and prescribing (Physician suite)
- Comprehensive planning automation (Dosimetry suite)
Use Cases
- Automating clinical preparation, documentation, and treatment planning in oncology workflows
- Assisting radiation oncologists with diagnosis, AI-powered prescriptions, and outcomes tracking
- Transforming treatment planning with centralized management and automated planning for dosimetrists
- Suggesting treatment protocols based on prior plans for similar cancer patients using the Sigma module
- Reducing administrative burden and improving efficiency in cancer care delivery
- Enhancing clinical decision-making with AI-driven insights and evidence-based guidelines
Details
| Category | Clinical Decision Support & Reference |
| Pricing | Unknown — unknown |
| Deployment | Cloud-native infrastructure. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Unknown Lumonus has secured FDA approval for its Clinical Decision Support Software (CDSS) exemption applications for Lumonus Treatment Planning Automation and Lumonus AI, including the Sigma module. This exemption means the software does not diagnose or treat patients, ensures user control over decisions, does not contain patient-specific information, requires professional input, and poses minimal risk to patient safety. |
| Integrations | |
| EHR | Not specified |
| Specialties | All specialties |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Lumonus AI
Videos
Product demos, reviews, and walkthroughs for Lumonus AI.
No FAQs available yet for this tool.